N@N

InVivo Therapeutics to Hold Business Update Conference Call on September 8th

^{Published on 2011-09-02 19:21:46 - Market Wire}
 

CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--InVivo Therapeutics Holdings Corp. (OTCBB:NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that the company will hold a conference call on September 8^th at 11:00 a.m. Eastern time during which Frank Reynolds, Chief Executive Officer, will provide a business update.

To participate in the conference call from the U.S. please dial 1-877-941-2068; from outside the U.S. please dial 1-480-629-9712. All listeners should reference the InVivo Therapeutics business update conference call and provide conference I.D. 4470404. Individuals interested in listening to the conference call live via the Internet may do so by logging onto the companya™s web site at [ www.invivotherapeutics.com ] and accessing the following link: [ http://www.invivotherapeutics.com/9-8-2011-conf-call/ ].

Following the completion of the conference call, a replay will be available from 2:00 p.m. Eastern time on September 8^th until midnight September 15^th, and can be accessed by dialing 1-877-870-5176 from the U.S. or 1-858-384-5517 from outside of the U.S. All listeners should provide passcode 4470404. The webcast will also be available for replay on the Companya™s website.

About InVivo Therapeutics

InVivo Therapeutics Holdings Corp. is focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of proprietary technology co-invented by Robert Langer, ScD. Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who is affiliated with Massachusetts General Hospital.

For more information please visit InVivoa™s web site at [ www.invivotherapeutics.com ].